Track the Hepion Pharmaceuticals, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €6.8m. The latest transaction was reported on 12 August 2026 (Acquisition). Among the most active insiders: LoPriore Vincent S. All data is accessible without an account.
15
Insider Decl.
n/a
Thresholds
€1m
15 ops.
Buy Volume
n/a
n/a
Sell Volume
72Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,600 shares@ US$5.4049.2% of flowCommon StockSEC:0001104659-23-101391:0
Canonical exit: 14 Dec 2023 (T+90)
15 of 15 declarations
Acerca de Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades hepáticas. Se concentra principalmente en la investigación y el desarrollo de medicamentos innovadores.